ISRCTN17585958已完成Unknown
Are patients undergoing chemotherapy who develop chemotherapy-induced neutropenia at greater risk for having oral lesions and periodontal diseases compared with patients without chemotherapy-induced neutropenia?
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •First group (patients with chemotherapy-induced neutropenia):
- •1. Patients diagnosed with hematological malignancy
- •2. Patients who received at least one cycle of chemotherapy
- •3. Patients developing neutropenia after chemotherapy, with an absolute neutrophil count (ANC) less than 1.5 x 10^9/L
- •Second group (patients without chemotherapy-induced neutropenia):
- •1. Patients diagnosed with hematological malignancy
- •2. The patient has received at least one cycle of chemotherapy
- •3. The patient does not present with post-chemotherapy neutropenia, and has an ANC greater than 1.5 x 10^9/
排除标准
- •1. Patients receive radiation therapy as part of their treatment
- •2. The patient has been diagnosed with oral cancer
- •3. The patient is diagnosed with a non-hematological malignancy
- •4. The patient is diagnosed with diabetes
研究者
相似试验
招募中
不适用
Comprehensive assessment of chemotherapy-induced cognitive dysfunction in patients with breast cancerpatients with breast cancerJPRN-UMIN000010330St. Luke international hospital100
已完成
不适用
Treatment response of chemotherapy in patient with lung cancer:evaluation of tumor blood flow using H215O-PET/CTlung cancerJPRN-UMIN000021847Osaka University Graduate School of Medicine30
进行中（未招募）
1 期
Clinical trial with chemotherapy for patients with non-resectable locally advanced pancreatic cancer and addition of chemo-radiotherapy for patients with borderline resectable pancreatic cancer. DPSG - ”Danish Pancreatic cancer Study Group”EUCTR2011-000703-40-DKOdense University Hospital53
已完成
2 期
Study of chemotherapy for patients with good prognosis metastatic non-seminomatous testicular cancerTesticular cancerCancerISRCTN79658966Medical Research Council (MRC) (UK)44
进行中（未招募）
不适用
eoadjuvant chemotherapy in patients affected by prostatic cancer locally advanced (non metastatic. Phase II study - NDPatients with histologically proven prostate adenocarcinoma (non metastatic)MedDRA version: 9.1Level: LLTClassification code 10029096Term: Neoplasm prostateEUCTR2007-002909-49-ITG.O.N.O. - GRUPPO ONCOLOGICO NORD OVEST